• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ROTAPRO; CATHETER, CORONARY, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ROTAPRO; CATHETER, CORONARY, ATHERECTOMY Back to Search Results
Model Number 3243
Device Problems Difficult to Remove (1528); Infusion or Flow Problem (2964)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/31/2019
Event Type  malfunction  
Manufacturer Narrative
Age at time of event: 18 years or older.
 
Event Description
It was reported that removal difficulties occurred.A 1.25mm rotapro was selected for a percutaneous coronary intervention (pci) procedure of the circumflex artery (cfx).The rotapro was prepared and advanced to the target lesion.After the first ablation was completed successfully with 3-5 passes for 30 seconds, the device was put into dynaglide mode but it was difficult to remove from the patient and blood was observed in the sheath.The physician then removed the device by pulling the device.The procedure was completed with balloon angioplasty instead of rotapro.There were no patient complications reported and the patient's status was stable post procedure.
 
Manufacturer Narrative
Device evaluated by manufacturer: returned product consisted of a rotapro device.Visual inspection of the analysis of the returned product revealed that the rotawire was stuck in burr and able to be removed from the advancer unit; however the wire was unable to be removed from the burr catheter after being soaked in a water bath for 4 days.Microscopic examination of the device revealed that the coil is stretched and there is blood in the entire length of the sheath.Functional testing was performed by attempting to rotate the drive shaft, however, it was unable to rotate due to the melted ultem.A melted ultem is due to the interruption of saline, by insufficient flow of saline used during the preparation or during the procedure of the device.Inspection of the remainder of the device presented no other damage or irregularities.A2: age at time of event: 18 years or older.
 
Event Description
It was reported that removal difficulties occurred.A 1.25mm rotapro was selected for a percutaneous coronary intervention (pci) procedure of the circumflex artery (cfx).The rotapro was prepared and advanced to the target lesion.After the first ablation was completed successfully with 3-5 passes for 30 seconds, the device was put into dynaglide mode but it was difficult to remove from the patient and blood was observed in the sheath.The physician then removed the device by pulling the device.The procedure was completed with balloon angioplasty instead of rotapro.There were no patient complications reported and the patient's status was stable post procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROTAPRO
Type of Device
CATHETER, CORONARY, ATHERECTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key9347998
MDR Text Key170338642
Report Number2134265-2019-14089
Device Sequence Number1
Product Code MCX
UDI-Device Identifier08714729893356
UDI-Public08714729893356
Combination Product (y/n)N
PMA/PMN Number
P900056
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 01/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number3243
Device Catalogue Number3243
Device Lot Number0023925840
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/22/2019
Initial Date Manufacturer Received 10/31/2019
Initial Date FDA Received11/20/2019
Supplement Dates Manufacturer Received12/23/2019
Supplement Dates FDA Received01/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-